Home

Cynthia Louise Flowers

CIK 1741455 · last filed 2026-01-13

Cynthia Louise Flowers is a corporate insider who has filed 24 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for LSTA, was dated Jan 13, 2026. Across all open-market trades the lifetime net is +$126.6K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $110.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$110.7K

Companies

4

Total Filings

24

Lifetime Open-Market Net

$126.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LSTA Director 95,446 $1.16 $110.7K $0 4 2026-01-13
G1 Therapeutics, Inc. (GTHX) Delisted Director 15,889 $7.15 $113.6K $26.2K 9 2024-09-18
LISATA THERAPEUTICS, INC. (CLBS) Delisted Director 9,723 $6.40 $62.2K $0 5 2022-01-12
Kadmon Holdings, Inc. (KDMN) Delisted Director 0 $9.50 $0 $100.4K 6 2021-11-09

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-13 LSTA Grant (A) +30,456 $0 EDGAR
2025-01-13 LSTA Grant (A) +15,789 $0 EDGAR
2024-09-18 G1 Therapeutics, Inc. (GTHX) Delisted Mixed −35,889 $0 EDGAR
2024-06-14 G1 Therapeutics, Inc. (GTHX) Delisted Grant (A) +10,000 $0 EDGAR
2024-01-11 LSTA Grant (A) +19,480 $0 EDGAR
2023-06-16 G1 Therapeutics, Inc. (GTHX) Delisted Grant (A) +10,000 $0 EDGAR
2023-01-11 LSTA Grant (A) +20,000 $0 EDGAR
2022-06-24 G1 Therapeutics, Inc. (GTHX) Delisted Grant (A) +10,000 $0 EDGAR
2022-01-12 LISATA THERAPEUTICS, INC. (CLBS) Delisted Grant (A) +65,430 $0 EDGAR
2021-11-09 Kadmon Holdings, Inc. (KDMN) Delisted Mixed −31,000 -$103.1K EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.